Sullivan Mark

US insider· US
Sign in for alerts
  • REDUCEDT+30

    Definium Therapeutics Inc · NASDAQ

    −14,051 sh · $513.8K

    Filed 29 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    Definium Therapeutics Inc · NASDAQ

    +125,000 sh

    Filed 14 Sept 2026SEC Form 4view source